Latest in Cardiology from ACC.org

• Advocacy in Sports Cardiology: From Sidelines to Statehouses
  Advocacy has become an increasingly important component of sports cardiology. As public attention surrounding sudden cardiac arrest (SCA) in athletes continues to grow, sports cardiologists are often asked to engage beyond the clinic by helping shape policies related to cardiovascular (CV) screening, emergency preparedness, and access to life-saving interventions.
• AI-Enabled Clinician: Chronic Cardiovascular Care in the Digital Age
  In this episode, Dr. Ami Bhatt speaks with Dr. Leslie Davis about how digital health tools are empowering patients to get ahead of symptom progression and helping underserved communities adopt at-home care.
• ACC Comments on 2027 Hospital OPPS and ASC Proposed Rule
  The ACC submitted formal comments to the Centers for Medicare and Medicaid Services (CMS) on the 2027 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System proposed rule on Aug. 25.
• LCZ in nHCM: Sacubitril/Valsartan Promotes Cardiac Remodeling, But Not Functional Capacity, in Nonobstructive HCM
  Functional capacity as measured by peak oxygen uptake (pVO2) was not improved with sacubitril/valsartan (LCZ696) in patients with nonobstructive hypertrophic cardiomyopathy (nHCM), while there was favorable cardiac structural remodeling, according to research published Aug. 19 in JACC: Heart Failure.
• FINE-HEART Post-Hoc Analysis Shows Finerenone Benefits Patients With CKM Syndrome Regardless of Cancer History
  In patients with cardio-kidney-metabolic (CKM) syndrome, comorbid cancer was frequent and independently associated with worse outcomes but did not affect the treatment benefit of finerenone, according to a post-hoc analysis of the FINE-HEART pooled analysis published Aug. 18 in EHJ.